These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3311209)

  • 1. Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms.
    Bretagne S; Vidaud M; Kuentz M; Cordonnier C; Henni T; Vinci G; Goossens M; Vernant JP
    Blood; 1987 Nov; 70(5):1692-5. PubMed ID: 3311209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
    Mackinnon S; Barnett L; Bourhis JH; Black P; Heller G; O'Reilly RJ
    Blood; 1992 Dec; 80(12):3235-41. PubMed ID: 1467526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation.
    Bertheas MF; Maraninchi D; Lafage M; Fraisse J; Blaise D; Stoppa AM; Michel G; Brizard CP; Gaspard MH; Novakovitch G
    Blood; 1988 Jul; 72(1):89-93. PubMed ID: 3291987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse.
    Wiesneth M; Schreiner T; Bunjes D; Bischof C; Erne E; Maccari B; Kubanek B
    J Hematother; 1999 Jun; 8(3):269-74. PubMed ID: 10417050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
    Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
    Pediatr Transplant; 1998 May; 2(2):150-6. PubMed ID: 10082448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse.
    Roux E; Abdi K; Speiser D; Helg C; Chapuis B; Jeannet M; Roosnek E
    Blood; 1993 Jan; 81(1):243-8. PubMed ID: 8417794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation.
    Yam PY; Petz LD; Knowlton RG; Wallace RB; Stock AD; de Lange G; Brown VA; Donis-Keller H; Blume KG
    Transplantation; 1987 Mar; 43(3):399-407. PubMed ID: 2881382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
    Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerism studies using in situ hybridization for the Y chromosome after T cell-depleted bone marrow transplantation.
    Przepiorka D; Gonzales-Chambers R; Winkelstein A; Rosenfeld C; Shadduck RK
    Bone Marrow Transplant; 1990 Apr; 5(4):253-7. PubMed ID: 2337737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic evidence of partial chimerism after T cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients.
    Berthéas MF; Mascret B; Maraninchi D; Lafage M; Blaise D; Fraisse J; Brizard CP; Carcassonne Y; Mawas C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2738-40. PubMed ID: 3547951
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.
    Mackinnon S; Barnett L; Heller G; O'Reilly RJ
    Blood; 1994 Jun; 83(11):3409-16. PubMed ID: 8193379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms.
    Ginsburg D; Antin JH; Smith BR; Orkin SH; Rappeport JM
    J Clin Invest; 1985 Feb; 75(2):596-603. PubMed ID: 3882761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction.
    Roux E; Helg C; Chapuis B; Jeannet M; Roosnek E
    Blood; 1992 May; 79(10):2775-83. PubMed ID: 1586724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.
    Offit K; Burns JP; Cunningham I; Jhanwar SC; Black P; Kernan NA; O'Reilly RJ; Chaganti RS
    Blood; 1990 Mar; 75(6):1346-55. PubMed ID: 2310831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete chimerism in erythroid, myeloid and B lymphocyte lineage after T cell-depleted allogeneic bone marrow transplantation.
    Schouten HC; Sizoo W; van 't Veer MB; Hagenbeek A; Löwenberg B
    Bone Marrow Transplant; 1988 Sep; 3(5):407-12. PubMed ID: 3056549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a single probe for documentation of chimerism following bone marrow transplantation.
    Yam P; Petz LD; Ali S; Stock AD; Wallace RB
    Am J Hum Genet; 1987 Nov; 41(5):867-81. PubMed ID: 2890295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.